Skip to main content
OpenTrials

Clinical trial condition

Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent

Explore clinical trials studying Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent. Study availability and eligibility vary by location and protocol.

4 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent trial results

Recruiting

HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT05745714

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 33 locations
View Trial Details
Recruiting

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

NCT05658640

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 36 locations
View Trial Details
Recruiting

HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT05751044

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 33 locations
View Trial Details

Related conditions